Healthcare names are being valued for recurring need and pricing power
This theme has appeared in 1 daily market analyses, first identified on Jul 19, 2026, most recently on Jul 19, 2026.
Every Mention of This Trend
Jul 19, 2026
Companies tied to healthcare services and critical medical products are drawing attention because demand is less dependent on economic cycles.
Supporting data: Steris reported roughly $5 billion in revenue with 8%-9% growth; DaVita generates around $12 billion annually with debt of $8.5-$9 billion and leverage of 3.5-4.0x EBITDA; Boston Scientific reported fiscal 2025 net sales of about $16.0 billion, up 10%, and operating income of $3.0 billion, up around 20%.